1. Home
  2. SDA vs BNR Comparison

SDA vs BNR Comparison

Compare SDA & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SDA

SunCar Technology Group Inc.

N/A

Current Price

$0.72

Market Cap

79.8M

Sector

Finance

ML Signal

N/A

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

N/A

Current Price

$9.31

Market Cap

94.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SDA
BNR
Founded
2007
2014
Country
China
China
Employees
N/A
N/A
Industry
Blank Checks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
79.8M
94.4M
IPO Year
2022
2019

Fundamental Metrics

Financial Performance
Metric
SDA
BNR
Price
$0.72
$9.31
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$4.75
N/A
AVG Volume (30 Days)
55.3K
4.2K
Earning Date
04-28-2026
06-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$12.01
$111.65
Revenue Next Year
$15.55
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.47
$6.79
52 Week High
$2.93
$41.72

Technical Indicators

Market Signals
Indicator
SDA
BNR
Relative Strength Index (RSI) 38.89 53.93
Support Level $0.72 $8.69
Resistance Level $0.86 $10.00
Average True Range (ATR) 0.06 0.52
MACD -0.00 0.07
Stochastic Oscillator 2.33 50.58

Price Performance

Historical Comparison
SDA
BNR

About SDA SunCar Technology Group Inc.

SunCar Technology Group Inc operates digital automotive aftersales market service platform and vehicle insurance technology platform. It develops and operates online platforms that connect drivers in China with a range of aftermarket automotive services and insurance coverage options from a nationwide network of service providers. These comprehensive digital systems are built on SunCar's multi-tenant, cloud-based platform. Revenues from its continuing operations are mainly generated from providing auto eInsurance services, technology services, and auto services.

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.

Share on Social Networks: